ÂÜÀòÂÒÂ×

The Research and Development team at Oric Pharmaceuticals is responsible for discovering and developing innovative oncology treatments targeting mechanisms of resistance. They work on advancing the company's pipeline, including the lead asset ORIC-101, by conducting preclinical and clinical research, managing regulatory affairs, developing formulations and drug delivery systems, and utilizing data science and bioinformatics to support their findings.